Welcome to our dedicated page for Willis Towers SEC filings (Ticker: WTW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Willis Towers Watson Public Limited Company filings document regulatory disclosures for an Ireland-incorporated advisory, broking and solutions company with ordinary shares listed on Nasdaq. The record includes Form 8-K reports for quarterly and annual results, Regulation FD materials, non-GAAP reconciliations and amended earnings disclosures.
Proxy materials describe board matters, executive compensation and shareholder voting. Other material-event filings cover definitive agreements, financing arrangements including a delayed-draw term loan facility, registered security information and capital-structure disclosures tied to WTW's operating businesses and acquisition activity.
Faber Alexis reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson PLC Chief Operating Officer Alexis Faber reported routine equity-based compensation. She received restricted share units representing 7.9767 and 3.4863 WTW Ordinary Shares, plus 5.5310 Ordinary Shares credited as dividends under non-qualified employee plans. These awards are granted at no cash cost and settle in shares on a 1:1 basis after termination or separation, with no open-market buying or selling disclosed. Following these grants, she holds 2548.6283 and 1064.4589 restricted share units and 10722.5930 Ordinary Shares directly, plus 1 Ordinary Share indirectly through an immediate family member.
Willis Towers Watson PLC reported that Chief Human Resources Officer Kristy D. Banas received small equity-based awards tied to dividends and deferred compensation plans. On April 15, 2026, she acquired 3.8715 and 1.8154 restricted share units and 5.0990 ordinary shares, all at a stated price of $0.0000 per share.
The filing notes that dividend equivalent rights on restricted share units are economically equal to one ordinary share and follow the same vesting schedule. Certain restricted share units and vested shares under non-qualified U.S. employee plans settle into ordinary shares on a 1:1 basis after separation from service or death, based on the plan terms.
Qureshi Imran Ahmed reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson executive Imran Ahmed Qureshi received a grant of restricted share units tied to the company’s ordinary shares. The award covers 125.2971 units at an indicated value of $280.14 per unit, bringing his directly held restricted share units to 3,071.5596.
The restricted share units settle into ordinary shares on a 1:1 basis six months after Qureshi’s termination date. The total includes units credited under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees through his own deferral elections and the company’s matching contributions.
Pullum Anne reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson Co-Head of Corporate Development Anne Pullum received a grant of 125.9765 restricted share units valued at $280.14 per unit. Following this award, she holds 2,560.4845 restricted share units directly.
The restricted share units settle into ordinary shares on a 1:1 basis six months after her termination date. The total includes units credited under the company’s Non-Qualified Deferred Savings Plan for U.S. Employees through her deferral elections and related company matching contributions.
Kurpis Joseph Stephen reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson PLC officer Joseph Stephen Kurpis received a small grant of restricted share units tied to the company’s ordinary shares. The award covers 0.0725 restricted share units at a reference price of $280.1400 per unit, bringing his reported restricted share unit holdings to 409.8291 units.
Each restricted share unit is designed to settle into one ordinary share with a nominal value of $0.000304635 per share. Settlement occurs on a 1:1 basis six months after Kurpis’s termination date, and the holdings include units credited under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees, reflecting both his deferral elections and related company matching contributions.
Krasner Andrew Jay reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson CFO Andrew Jay Krasner reported an award of 480.7592 restricted share units on April 10, 2026 at a reference price of $280.14 per unit. Following this grant, he holds 2,558.1044 restricted share units directly. These units settle into ordinary shares on a 1:1 basis six months after his termination date and include units credited under the company’s Non-Qualified Deferred Savings Plan, reflecting both his deferral elections and related company matching contributions.
Willis Towers Watson plc Chief Executive Officer Carl Aaron Hess reported an acquisition of 773.4257 Restricted Share Units on Ordinary Shares at $280.1400 per share. These units are part of his compensation and increase his directly held restricted share units to 10,406.6758.
The restricted share units convert into Ordinary Shares on a 1:1 basis and settle six months after Hess’s termination date. The total includes units credited under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees, reflecting both his deferral elections and the company’s matching contributions.
Willis Towers Watson PLC reported that executive Julie Jarecke Gebauer, President of Health, Wealth & Career, received a grant of 373.7073 restricted share units on Ordinary Shares. These units were valued at $280.1400 per unit for reporting purposes and increase her direct holdings to 24,342.2604 restricted share units.
According to the filing, the restricted share units convert into Ordinary Shares with a nominal value of $0.000304635 per share on a 1:1 basis, settling six months after her termination date. The total includes units credited under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees, reflecting both her deferral elections and the company’s matching contributions.
Furman Matthew reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson General Counsel Matthew Furman received a compensation-related equity grant. On this Form 4, he was awarded 244.4871 restricted share units at a reference price of $280.14 per unit, increasing his directly held restricted share units to 3,607.7646. These units settle into Ordinary Shares on a 1:1 basis six months after his termination date and include restricted share units credited under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees, reflecting both his deferral elections and the company’s matching contributions.
Faber Alexis reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson Chief Operating Officer Alexis Faber received a grant of 113.1385 restricted share units on Ordinary Shares, recorded at a reference price of $280.14 per share. After this award, her directly held restricted share units total 2,540.6516.
The restricted share units settle into Ordinary Shares on a 1:1 basis six months after her termination date. The total includes units credited under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees, reflecting both her deferral elections and the company’s matching contributions.